LILRB3 and central nervous system cancer: indicates that LILRB3 is predominantly expressed on monocyte-derived tumor-associated macrophages (Mo-TAMs) in gliomas, with high LILRB3 expression serving as an independent negative prognostic factor across various glioma grades [8].